Does improved insulin sensitivity by irbesartan at the highest tolerated dose provide a benefit in non-diabetic patients with systolic heart failure already receiving standardized treatment?

• Authors: Dan Yang, Zhihong Liu
• Journal: International journal of cardiology (Int J Cardiol) Vol. 168 Issue 2 Pg. 1572-3 (Sep 30 2013) ISSN: 1874-1754 [Electronic] Netherlands
• PMID: 23434005 (Publication Type: Letter, Comment)

Chemical References

• Angiotensin Receptor Antagonists
• Biphenyl Compounds
• Tetrazoles

Topics

• Angiotensin Receptor Antagonists (therapeutic use)
• Biphenyl Compounds (therapeutic use)
• Female
• Heart Failure, Systolic (drug therapy, physiopathology)
• Humans
• Insulin Resistance (physiology)
• Male
• Tetrazoles (therapeutic use)